165 related articles for article (PubMed ID: 16822721)
21. [Dyslipidemia in diabetes mellitus].
Niemeijer-Kanters SD; Banga JD; Erkelens DW
Ned Tijdschr Geneeskd; 2001 Apr; 145(16):769-74. PubMed ID: 11346913
[TBL] [Abstract][Full Text] [Related]
22. [Obesity and the metabolic syndrome].
Masuzaki H; Nakao K
Nihon Rinsho; 2005 Feb; 63 Suppl 2():264-8. PubMed ID: 15779384
[No Abstract] [Full Text] [Related]
23. Metabolic syndrome: a closer look at the growing epidemic and its associated pathologies.
O'Neill S; O'Driscoll L
Obes Rev; 2015 Jan; 16(1):1-12. PubMed ID: 25407540
[TBL] [Abstract][Full Text] [Related]
24. Summaries for patients. Use of common laboratory tests to identify people with insulin resistance.
Ann Intern Med; 2003 Nov; 139(10):I16. PubMed ID: 14623638
[No Abstract] [Full Text] [Related]
25. Increased susceptibility of LDL to in vitro oxidation in patients with insulin-dependent and non-insulin-dependent diabetes mellitus.
Cominacini L; Garbin U; Pastorino AM; Fratta Pasini A; Campagnola M; De Santis A; Davoli A; Lo Cascio V
Diabetes Res; 1994; 26(4):173-84. PubMed ID: 7648791
[TBL] [Abstract][Full Text] [Related]
26. Persistent lipid abnormalities in statin-treated patients with diabetes mellitus in Europe and Canada: results of the Dyslipidaemia International Study.
Leiter LA; Lundman P; da Silva PM; Drexel H; Jünger C; Gitt AK;
Diabet Med; 2011 Nov; 28(11):1343-51. PubMed ID: 21679231
[TBL] [Abstract][Full Text] [Related]
27. Frequency of metabolic syndrome among hemodialysis patients according to NCEP-ATP III and IDF definitions.
Ucar E; Huzmeli C; Guven O; Savas N; Gullu M; Asilyoruk S; Kuvandik C; Temizkan A; Kuvandik G
Ren Fail; 2009; 31(3):221-8. PubMed ID: 19288328
[TBL] [Abstract][Full Text] [Related]
28. Does diagnosis of the metabolic syndrome detect further men at high risk of cardiovascular death beyond those identified by a conventional cardiovascular risk score? The DECODE Study.
DECODE Study Group
Eur J Cardiovasc Prev Rehabil; 2007 Apr; 14(2):192-9. PubMed ID: 17446796
[TBL] [Abstract][Full Text] [Related]
29. Relationship between adiponectin and metabolic variables in Caribbean offspring of patients with type 2 diabetes mellitus.
Ezenwaka CE; Kalloo R; Uhlig M; Eckel J
Horm Metab Res; 2004 Apr; 36(4):238-42. PubMed ID: 15114523
[TBL] [Abstract][Full Text] [Related]
30. Glucose, insulin, diabetes and mechanisms of arterial dysfunction.
Cameron JD; Cruickshank JK
Clin Exp Pharmacol Physiol; 2007 Jul; 34(7):677-82. PubMed ID: 17581229
[TBL] [Abstract][Full Text] [Related]
31. Triglyceride-to-HDL-cholesterol ratio and metabolic syndrome as contributors to cardiovascular risk in overweight patients.
Marotta T; Russo BF; Ferrara LA
Obesity (Silver Spring); 2010 Aug; 18(8):1608-13. PubMed ID: 20019684
[TBL] [Abstract][Full Text] [Related]
32. Epidemiology of Gender Differences in Diabetes and Obesity.
Mauvais-Jarvis F
Adv Exp Med Biol; 2017; 1043():3-8. PubMed ID: 29224087
[TBL] [Abstract][Full Text] [Related]
33. The 10-year post-trial follow-up of the United Kingdom Prospective Diabetes Study (UKPDS): cardiovascular observations in context.
Gore MO; McGuire DK
Diab Vasc Dis Res; 2009 Jan; 6(1):53-5. PubMed ID: 19156632
[No Abstract] [Full Text] [Related]
34. High prevalence of abdominal obesity increases the risk of the metabolic syndrome in Nigerian type 2 diabetes patients: using the International Diabetes Federation worldwide definition.
Ezenwaka CE; Okoye O; Esonwune C; Onuoha P; Dioka C; Osuji C; Oguejiofor C; Meludu S
Metab Syndr Relat Disord; 2014 Jun; 12(5):277-82. PubMed ID: 24601861
[TBL] [Abstract][Full Text] [Related]
35. [The role of adiponectin in pathogenesis of metabolic syndrome and cardiovascular disease].
Kozłowska A; Kowalska I
Endokrynol Pol; 2006; 57(6):626-32. PubMed ID: 17253436
[TBL] [Abstract][Full Text] [Related]
36. Non-high-density-lipoprotein cholesterol and cardiovascular risk factors among adolescents with and without impaired fasting glucose.
Liu J; Joshi D; Sempos CT
Appl Physiol Nutr Metab; 2009 Apr; 34(2):136-42. PubMed ID: 19370043
[TBL] [Abstract][Full Text] [Related]
37. Screening for insulin resistance and cardiovascular risk in collegiate football linemen.
Haskins S; Bernhardt DT; Koscik RL
Clin J Sport Med; 2011 May; 21(3):233-6. PubMed ID: 21490503
[TBL] [Abstract][Full Text] [Related]
38. Metabolic syndrome and autoimmune diabetes: action LADA 3.
Hawa MI; Thivolet C; Mauricio D; Alemanno I; Cipponeri E; Collier D; Hunter S; Buzzetti R; de Leiva A; Pozzilli P; Leslie RD;
Diabetes Care; 2009 Jan; 32(1):160-4. PubMed ID: 18945926
[TBL] [Abstract][Full Text] [Related]
39. The association of obesity, metabolic syndrome, diabetes, and cardiovascular disease with nonalcoholic fatty liver disease.
Bell DS
South Med J; 2009 Oct; 102(10):991-2. PubMed ID: 19738529
[No Abstract] [Full Text] [Related]
40. Are the results really different?
Reaven GM
Diabetes Care; 2000 Jul; 23(7):1040. PubMed ID: 10895876
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
